HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroaki Matsuno Selected Research
Hiroaki Matsuno Research Topics
Disease
30
Rheumatoid Arthritis
07/2023 - 09/2001
7
Infections
07/2023 - 01/2006
2
Neoplasms (Cancer)
07/2023 - 05/2002
2
Hypersensitivity (Allergy)
08/2021 - 01/2006
2
Arthritis (Polyarthritis)
01/2019 - 12/2007
2
Synovitis
01/2011 - 02/2004
2
Pain (Aches)
01/2010 - 02/2009
2
Osteoarthritis
02/2009 - 01/2004
2
Inflammation (Inflammations)
12/2007 - 02/2004
2
Lymphadenopathy
01/2006 - 01/2006
2
Asthma (Bronchial Asthma)
01/2006 - 10/2005
2
Eosinophilia
01/2006 - 10/2005
1
Herpes Zoster
07/2023
1
Ankylosing Spondylitis
08/2022
1
Non-Radiographic Axial Spondyloarthritis
08/2022
1
Necrosis
05/2020
1
Drug-Related Side Effects and Adverse Reactions
03/2019
1
Interstitial Lung Diseases (Interstitial Lung Disease)
03/2019
1
Bone Resorption
01/2019
1
Hemorrhage
09/2017
1
Postmenopausal Osteoporosis
12/2016
1
Osteoporosis
12/2016
1
Symptom Flare Up
05/2013
1
Experimental Arthritis
01/2011
1
Osteomyelitis
10/2006
1
Pulmonary Eosinophilia (Eosinophilic Pneumonia)
01/2006
1
Eosinophilic enteropathy
01/2006
1
Fever (Fevers)
01/2006
1
Glycogen Storage Disease Type VI (Glycogenosis Type VI)
01/2006
1
Lymphocytosis
01/2006
1
Rheumatoid Nodule
01/2006
1
Sarcoidosis (Schaumann Disease)
01/2006
1
Anterior Uveitis
01/2006
1
Virus Diseases (Viral Diseases)
01/2006
1
Dyspnea (Shortness of Breath)
10/2005
1
Liver Diseases (Liver Disease)
10/2005
1
Sepsis (Septicemia)
10/2005
1
Heart Failure
10/2005
Drug/Important Bio-Agent (IBA)
6
Methotrexate (Mexate)
FDA Link
Generic
05/2022 - 01/2006
4
Biosimilar Pharmaceuticals
IBA
05/2022 - 01/2018
4
tocilizumab (atlizumab)
FDA Link
05/2020 - 05/2013
4
Antirheumatic Agents (DMARD)
IBA
05/2020 - 01/2016
4
Proteins (Proteins, Gene)
FDA Link
03/2019 - 02/2009
4
Etanercept (Enbrel)
FDA Link
01/2019 - 12/2010
3
Infliximab (Remicade)
FDA Link
11/2019 - 12/2007
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019 - 02/2004
3
Anti-Bacterial Agents (Antibiotics)
IBA
10/2006 - 10/2005
2
Antigens
IBA
08/2021 - 01/2004
2
golimumab
FDA Link
05/2020 - 03/2017
2
glucose utilization inhibitor (IGU)
IBA
03/2019 - 09/2017
2
iguratimod
IBA
03/2019 - 09/2017
2
LBEC0101
IBA
01/2019 - 01/2018
2
Glucocorticoids
IBA
09/2017 - 12/2016
2
Interleukin-6 (Interleukin 6)
IBA
01/2015 - 12/2007
2
Hyaluronic Acid (Hyaluronan)
IBA
02/2009 - 03/2006
2
calpastatin
IBA
01/2005 - 01/2004
2
Monoclonal Antibodies
IBA
12/2003 - 08/2002
1
baricitinib
IBA
07/2023
1
tofacitinib
IBA
07/2023
1
Janus Kinase Inhibitors
IBA
07/2023
1
HLA Antigens (Human Leukocyte Antigens)
IBA
08/2022
1
Adalimumab (Humira)
FDA Link
05/2022
1
Abatacept (Orencia)
FDA Link
05/2020
1
Tumor Necrosis Factor Inhibitors
IBA
05/2020
1
Calcineurin Inhibitors
IBA
01/2019
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2019
1
Tacrolimus (Prograf)
FDA Link
Generic
01/2019
1
Warfarin (Coumadin)
FDA Link
Generic
09/2017
1
Therapeutic Uses
IBA
12/2016
1
Diphosphonates (Bisphosphonates)
IBA
12/2016
1
RANK Ligand
IBA
12/2016
1
Parathyroid Hormone (Parathormone)
IBA
12/2016
1
Denosumab
FDA Link
12/2016
1
Sulfasalazine (Azulfidine)
FDA Link
Generic
01/2016
1
bucillamine (SA 96)
IBA
01/2016
1
Immunoglobulins (Immunoglobulin)
IBA
01/2011
1
Quercetin
IBA
02/2009
1
Glucosamine (Dona)
IBA
02/2009
1
Chondroitin
IBA
02/2009
1
Glucosides
IBA
02/2009
1
Agar
IBA
10/2006
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
02/2006
1
Calcium
IBA
01/2006
1
DNA (Deoxyribonucleic Acid)
IBA
01/2006
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2006
1
Muramidase (Lysozyme)
IBA
01/2006
1
Sulfamethoxazole
FDA Link
Generic
01/2006
1
Thymidine Monophosphate (TMP)
IBA
01/2006
1
Trimethoprim (Proloprim)
FDA Link
Generic
01/2006
1
Tuberculin (PPD)
IBA
01/2006
1
Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
FDA Link
Generic
01/2006
1
Rheumatoid Factor
IBA
11/2005
1
Biomarkers (Surrogate Marker)
IBA
11/2005
1
Immunoglobulin M (IgM)
IBA
11/2005
Therapy/Procedure
4
Therapeutics
12/2007 - 05/2002
2
Activities of Daily Living (ADL)
05/2022 - 01/2010
1
Perioperative Period
05/2013
1
Oral Administration
02/2009
1
Biological Therapy
12/2007
1
Arthroplasty
10/2006